Table 1.
%ChAT(+) Cells Labeled by Cy3-p75NTR-IgG | %Cy3-p75NTR-IgG(+) Cells ChAT(−) | No. of ChAT(+) Cells | No. of Cy3-p75NTR-IgG(+) Cells | |
---|---|---|---|---|
MS ipsilateral | 57.7 ± 4.5 | 5.5 ± 0.9 | 982 | 639 |
MS contralateral | 58.8 ± 4.6 | 4.5 ± 1.0 | 871 | 575 |
hDB ipsilateral | 53.6 ± 5.9 | 4.7 ± 1.8 | 1422 | 866 |
hDB contralateral | 58.3 ± 5.0 | 3.8 ± 0.8 | 1848 | 1172 |
MCPO ipsilateral | 50.2 ± 6.8 | 3.3 ± 1.5 | 1357 | 774 |
MCPO contralateral | 51.7 ± 6.9 | 3.4 ± 1.3 | 1605 | 882 |
SI ipsilateral | 44.6 ± 4.8 | 4.5 ± 1.6 | 485 | 237 |
SI contralateral | 43.1 ± 5.1 | 4.0 ± 1.9 | 640 | 279 |
Percentage values are means ± SE from 7 mice, indicating the percentage of choline acetyltransferase-positive [ChAT(+)] neurons labeled with indocarbocyanine-coupled antibodies raised against mouse p75 neutrophin receptors (Cy3-p75NTR-IgG) and the percentage of neurons labeled with Cy3-p75NTR-IgG that are ChAT(−). Cell counts were performed in the medial septum (MS), horizontal limb of the diagonal band (hDB), magnocellular preoptic nucleus (MCPO), and substantia innominata (SI) ipsilateral and contralateral to the Cy3-p75NTR-IgG intracerebroventricular injections.